Form 8-K - Current report:
SEC Accession No. 0001213900-25-100797
Filing Date
2025-10-21
Accepted
2025-10-21 15:57:59
Documents
16
Period of Report
2025-10-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0261839-8k_pmgc.htm   iXBRL 8-K 53278
2 AMENDMENT NO. 1 TO THE SECONDMENT AGREEMENT BETWEEN THE COMPANY AND GB CAPITAL L ea026183901ex10-1_pmgc.htm EX-10.1 20276
3 AMENDMENT NO. 1 TO THE SECONDMENT AGREEMENT BETWEEN THE COMPANY AND NORTHSTRIVE ea026183901ex10-2_pmgc.htm EX-10.2 24344
4 AMENDMENT NO.4 TO THE CONSULTING AND SERVICES AGREEMENT FOR NON-EMPLOYEE CHIEF E ea026183901ex10-3_pmgc.htm EX-10.3 24376
5 AMENDMENT NO. 4 TO THE CONSULTING AND SERVICES AGREEMENT FOR NON-EMPLOYEE, NON-E ea026183901ex10-4_pmgc.htm EX-10.4 18440
  Complete submission text file 0001213900-25-100797.txt   334974

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE elab-20251016.xsd EX-101.SCH 3026
7 XBRL LABEL FILE elab-20251016_lab.xml EX-101.LAB 34239
8 XBRL PRESENTATION FILE elab-20251016_pre.xml EX-101.PRE 22366
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0261839-8k_pmgc_htm.xml XML 3797
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 888-445-4886
PMGC Holdings Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 251406967
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)